top of page
Somagenetix Insights
Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD)
Zurich, Switzerland, October 08, 2024 – Somagenetix AG , a pioneering biotech company dedicated to revolutionizing gene therapy for...
Somagenetix
Oct 11, 20243 min read
bottom of page